IGF-DES 1,3Check methods and identity
Why protein measurements and glucose measurements diverged in a diabetes model
2 numbered sourcesSource years 1989, 1991
Peptide bonds join amino acids into short chains called peptides. Growth factors built from amino acids can affect several aspects of metabolism. IGF-DES 1,3 refers here to des(1–3)IGF-1, the form missing the first three residues of mature insulin-like growth factor 1. An animal experiment asked how the shortened variant affected protein metabolism in rats with experimentally induced diabetes. [1, 2]
No recent primary study directly repeating this comparison was identified. In older work, the investigators compared full-length IGF-1 and the truncated variant with controls and with other hormone exposures in rats. They followed body weight, estimated nitrogen retention and measured protein synthesis in muscle. The shortened variant increased several of these measures compared with the injured metabolic state in control animals. The investigators found that increased synthesis contributed to the change in the body's overall nitrogen balance. [1]
They also looked at glucose in the urine. The IGF-related peptides did not reduce this sign of abnormal carbohydrate metabolism in the way insulin did in the experiment. The outcomes illustrate why protein synthesis, protein breakdown and glucose regulation should be assessed separately. A compound that changes one of these measures can have a different pattern on the others. [1]
The study describes a short period in a particular rat model. Protein synthesis measured under those conditions does not establish muscle strength or physical function, and the glucose result provides no evidence for treating human diabetes with the variant. The older findings are useful for understanding why a metabolic claim needs to identify the endpoint it is based on. [1]
Sources
Original works cited in this article. Links open the external record in a new tab.
